APLS
Price
$19.47
Change
-$0.28 (-1.42%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
2.45B
24 days until earnings call
KYMR
Price
$46.19
Change
-$0.16 (-0.35%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
3.25B
14 days until earnings call
Interact to see
Advertisement

APLS vs KYMR

Header iconAPLS vs KYMR Comparison
Open Charts APLS vs KYMRBanner chart's image
Apellis Pharmaceuticals
Price$19.47
Change-$0.28 (-1.42%)
Volume$46.43K
Capitalization2.45B
Kymera Therapeutics
Price$46.19
Change-$0.16 (-0.35%)
Volume$3.99K
Capitalization3.25B
APLS vs KYMR Comparison Chart in %
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. KYMR commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (APLS: $20.04 vs. KYMR: $46.35)
Brand notoriety: APLS and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 72% vs. KYMR: 44%
Market capitalization -- APLS: $2.45B vs. KYMR: $3.25B
APLS [@Biotechnology] is valued at $2.45B. KYMR’s [@Biotechnology] market capitalization is $3.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 6 TA indicator(s) are bullish while KYMR’s TA Score has 3 bullish TA indicator(s).

  • APLS’s TA Score: 6 bullish, 3 bearish.
  • KYMR’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, APLS is a better buy in the short-term than KYMR.

Price Growth

APLS (@Biotechnology) experienced а +2.61% price change this week, while KYMR (@Biotechnology) price change was +2.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

APLS is expected to report earnings on Nov 10, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.25B) has a higher market cap than APLS($2.45B). KYMR YTD gains are higher at: 15.213 vs. APLS (-37.198). APLS has higher annual earnings (EBITDA): -176.08M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. APLS (358M). KYMR has less debt than APLS: KYMR (86.3M) vs APLS (470M). APLS has higher revenues than KYMR: APLS (776M) vs KYMR (58.9M).
APLSKYMRAPLS / KYMR
Capitalization2.45B3.25B75%
EBITDA-176.08M-232.67M76%
Gain YTD-37.19815.213-245%
P/E RatioN/AN/A-
Revenue776M58.9M1,317%
Total Cash358M463M77%
Total Debt470M86.3M545%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSKYMR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 19 days ago
79%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDDVX20.800.10
+0.49%
BlackRock Equity Dividend Inv A
KMKNX80.35N/A
N/A
Kinetics Market Opportunities No Load
PARMX39.72N/A
N/A
Parnassus Mid-Cap
TOLIX16.39N/A
N/A
DWS RREEF Global Infrastructure Inst
MEYWX11.37N/A
N/A
Manning & Napier Equity Series W

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+1.85%
NRIX - KYMR
66%
Loosely correlated
-2.66%
VERA - KYMR
58%
Loosely correlated
+0.85%
IDYA - KYMR
54%
Loosely correlated
-0.27%
CGON - KYMR
54%
Loosely correlated
+9.13%
CCCC - KYMR
54%
Loosely correlated
+7.92%
More